Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Final Results of the Randomized Phase 2 LEO Trial and Bone Protective Effects of Everolimus for Premenopausal Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerInt. J. Cancer 2021 Apr 27;[EPub Ahead of Print], H Jeong, JH Jeong, JE Kim, JH Ahn, KH Jung, SJ Koh, J Cheon, J Sohn, GM Kim, KS Lee, SH Sim, IH Park, SB Kim
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.